Impact of Margin Status on Local Recurrence After Mastectomy for Ductal Carcinoma In Situ
Creators
- 1. Harvard Radiation Oncology Program, Boston, Massachusetts (United States)
- 2. Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts (United States)
- 3. Department of Surgery, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, Massachusetts (United States)
- 4. Department of Surgery, Faulkner Hospital, Boston, Massachusetts (United States)
- 5. Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts (United States)
- 6. Department of Pathology, Faulkner Hospital, Boston, Massachusetts (United States)
- 7. Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, Massachusetts (United States)
Description
Purpose: To examine the rate of local recurrence according to the margin status for patients with pure ductal carcinoma in situ (DCIS) treated by mastectomy. Methods and Materials: One hundred forty-five consecutive women who underwent mastectomy with or without radiation therapy for DCIS from 1998 to 2005 were included in this retrospective analysis. Only patients with pure DCIS were eligible; patients with microinvasion were excluded. The primary endpoint was local recurrence, defined as recurrence on the chest wall; regional and distant recurrences were secondary endpoints. Outcomes were analyzed according to margin status (positive, close (≤2 mm), or negative), location of the closest margin (superficial, deep, or both), nuclear grade, necrosis, receptor status, type of mastectomy, and receipt of hormonal therapy. Results: The primary cohort consisted of 142 patients who did not receive postmastectomy radiation therapy (PMRT). For those patients, the median follow-up time was 7.6 years (range, 0.6-13.0 years). Twenty-one patients (15%) had a positive margin, and 23 patients (16%) had a close (≤2 mm) margin. The deep margin was close in 14 patients and positive in 6 patients. The superficial margin was close in 13 patients and positive in 19 patients. One patient experienced an isolated invasive chest wall recurrence, and 1 patient had simultaneous chest wall, regional nodal, and distant metastases. The crude rates of chest wall recurrence were 2/142 (1.4%) for all patients, 1/21 (4.8%) for those with positive margins, 1/23 (4.3%) for those with close margins, and 0/98 for patients with negative margins. PMRT was given as part of the initial treatment to 3 patients, 1 of whom had an isolated chest wall recurrence. Conclusions: Mastectomy for pure DCIS resulted in a low rate of local or distant recurrences. Even with positive or close mastectomy margins, the rates of chest wall recurrences were so low that PMRT is likely not warranted
Availability note (English)
Available from http://dx.doi.org/10.1016/j.ijrobp.2012.07.2377Additional details
Identifiers
- DOI
- 10.1016/j.ijrobp.2012.07.2377;
- PII
- S0360-3016(12)03334-2;
Publishing Information
- Journal Title
- International Journal of Radiation Oncology, Biology and Physics
- Journal Volume
- 85
- Journal Issue
- 4
- Journal Page Range
- p. 948-952
- ISSN
- 0360-3016
- CODEN
- IOBPD3
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 46126192
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- CARCINOMAS; CHEST; METASTASES; NECROSIS; PATIENTS; RADIOTHERAPY; RECEPTORS; WOMEN
- Descriptors DEC
- ANIMALS; BODY; DISEASES; FEMALES; MAMMALS; MAN; MEDICINE; MEMBRANE PROTEINS; NEOPLASMS; NUCLEAR MEDICINE; ORGANIC COMPOUNDS; PATHOLOGICAL CHANGES; PRIMATES; PROTEINS; RADIOLOGY; THERAPY; VERTEBRATES
Optional Information
- Copyright
- Copyright (c) 2013 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.